EVALUATION OF EFFICACY AND SAFETY OF HEPATITIS C VIRUS TREATMENT WITH THE NEW DIRECT ACTING ANTIVIRALS IN THE CLINICAL PRACTICE OF A REGIONAL HOSPITAL